W11 WORKSHOP
Organised and supported the Lithuanian Presidency of the Council of the European Union 2013, EAPM, EFPIA, Pfizer, IBM and Vital Transformation
The ongoing IT revolution has made possible the ability to analyse enormous data sets from different locations. Volume, variety, velocity and value are the key characteristics of datasets feeding contemporary algorithms and improved data mining methodologies create new frontiers of statistical inference. Analytics continue to evolve, with their ability to consume and interpret terabits of data growing exponentially in power year on year.
Healthcare is an area where Big Data can have a tremendous impact, marking a transformation from human judgment to automated decisions for genomics, the development of new therapies, the monitoring of real world efficiency, and improving the timely delivery of care for patients.
This workshop will feature a panel of international experts from research, policy and industry discussing new ways to harness Big Data and translate it from the lab with better indications, improve our understanding of benefit risk, provide tools for more accurate health technology assessment, and reduce the dreaded efficacy/efficiency gap.
In the course of this workshop session we will discuss following topics:
• Big Data and best practice for public health
• Data sharing for improved research and translation
• Big Data and improved evaluation models for efficacy and efficiency
Big Data and best practice for public health
Amelia Andersdotter, Member of the European Parliament
Terje Peetso, Unit H1 - Health and Well Being, DG Connect, European Commission
Leonas Kaletinas, Member Board of Directors, Lithuanian Health Forum
Data sharing for improved research and translation
Barbara Kerstiens, Head of Sector Public health, DG Research, European Commission
Angela Brand, Prof. of Health, Medicine and Life Sciences, Maastricht University
Bonnie Wolff-Boenisch, Head of Research Affairs, Science Europe
Big Data and improved evaluation models for efficacy and efficiency
Ernst Hafen, Institute of Molecular Systems Biology, ETH Zurich
John Crawford, Healthcare Industry Leader Europe, IBM
Adam Heathfield, Director Science Policy Europe, Pfizer
Closing remarks
A Brand, Maastricht University
Moderation
D Schulthess, Managing Director, Vital Transformation